NCT05187104Enrolling By Invitation1 期
Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年3月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- Enrolling By Invitation
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- Visual acuity
研究概览
简要总结
Treatment of age-related macular degeneration using retinal stem and progenitor cells
详细描述
The aim of the project is to develop a biomedical cell product based on retinal pigment epithelium cells for highly effective treatment age-related macular degeneration; to conduct the clinical trials of the biomedical cell product in the treatment of age-related macular degeneration.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of age-related macular degeneration
- •The patient can read, understand, follow the examination procedures and complete, if necessary, the required documentation
- •Written informed consent
排除标准
- •The presence of any malignant tumor within the last 5 years
- •Acute or chronic diseases in the stage of decompensation
- •Chronic infectious diseases: HIV, viral hepatitis B, C, tuberculosis
- •Patients who are pregnant, breastfeeding, or fertile patients who are not using adequate contraceptive methods
- •Chronic and protracted mental disorders, all diseases with the presence of the syndrome of dependence on alcohol, drugs and psychoactive substances, any other condition that makes the patient unable to understand the nature, extent and possible consequences of the study or, in the opinion of the researcher, prevents the patient from observing and performing protocol
- •Patients are unable or unwilling to give written informed consent and / or follow research procedures
- •Any other medical condition that, in the opinion of the investigator, may be associated with an increased risk to the patient or may affect the outcome or evaluation of the study
结局指标
主要结局
Visual acuity
时间窗: 1 year
Determination of visual acuity after the therapy
Adverse effects associated with the therapy
时间窗: 1 year
Determination of adverse effects associated with the therapy
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
1 期
Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem CellsDry Age-related Macular DegenerationNCT03046407Chinese Academy of Sciences10
已完成
不适用
Research on age-related macular degeneration and diabetic complications using non-invasive AGEs measurement equipment.age-related macular degeneration, diabetic retinopathyJPRN-UMIN000010741Shinshu University Graduate School of Medicine, Department of Ophthalmology500
Unknown
不适用
Therapy of Age-related Macular DegenerationAge-Related Macular DegenerationNCT05222997Robert Hörantner150
已完成
不适用
Mechanisms of Retinal Revascularization and Clinical Indicators of Neovascular AMD RelapseWet Macular DegenerationNCT05211804Sorlandet Hospital HF31
已完成
1 期
The effect of saffron supplementation on vision in patients with early dry age-related macular degeneratioAge-related macular degenerationACTRN12612000729820The University of Sydney100